BIT's 10th Annual International Congress of Antibodies (ICA-2018)
Introduction to ICA-2018

Following on the successful organizing of ICA-2017 Beijing, we are pleased to announce the 10th ICA congress will be held during March 23-25, 2018 in Washington, USA. With the theme of “The Future Star of Biomedicine”, we will once again offer professionals in the field of antibody a multidisciplinary informative platform.
ICA-2018 contributes to provide a unique platform which will bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, to present the latest research results, ideas, developments, applications and business prospects in Antibody Research and Technologies, Antibody Drugs, Antibody Therapy, Antibody Production, and Antibody Market Trend & Policy, etc.

Program Layout

Stream 1: Global Update on Antibodies Market Trends and Industry Strategies
Stream 2: Next-Generation Antibodies
Stream 3: Antibodies for Cancer Therapy
Stream 4: New Antibodies for Other Major Diseases
Stream 5: New Achievements in Antibody Research
Stream 6: Antibody Engineering and Production
Stream 7: Posters and Exhibitions

Stream 8: Social & Cultural Activities

Past International Renowned Speakers
Dr. Weikang Tao,
Vice President and CEO of R&D Center, Jiangsu Henrui Medicine Co., Ltd., China
Dr. Madi Madiyalakan, CEO, Quest PharmaTech Inc., Canada Dr. Dan Zhang,
Chairman and CEO, Fountain Medical Development Ltd. China
Dr. Yong Qian,
Chairman, BioMedicure Group, USA and China
Ms. Lidia Retkowska-Mika,
Director, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland
Dr. Weiping Shao, Director, Regeneron Pharmaceuticals, Inc., USA
Dr. Ulrich Storz,
Senior Partner, Michalski•Hüttermann & Partner, Germany
Dr. Achim Treumann, Director of NUPPA, University of Newcastle, UK Mr. Rezan Güler,
KTH, Royal Institute of Technology, Sweden
Mr. Mingjie Xie,
Co-founder and CEO, Rapid Novor, Inc., Canada
Dr. Ludovic Duponchel, Professor, University of Lille, France Dr. Xin Ge,
Assistant Professor, University of California, Riverside, USA
Dr. Steve Xiaofeng Yu, Director,Cyagen Biosciences, Inc. ,China Dr. Steve Davenport,
Vice President Global Sales, Intellicyt Corporation, USA
Dr. Yaoxiong Huang, Professor, Jinan University, China
Dr. Machinani Janardhan Rao,
CMC Principal Consultant, Woodbury Biologics Consulting LLC, USA
Dr. Jason Xiang,
VP and Co-Founder, XDC Explorer, Inc., China
Dr. Andrew Huang, Senior VP R&D, MabPlex International Ltd, China
Dr. Bruce Nianhe Han, Chief Scientific Officer, NewBio Therapeutics, China Dr. Shihua Wang , Professor, Fujian Agriculture and Forestry University , China Dr. Esther Una Cidon, Medical Oncologist, Royal Bournemouth Hospital NHS Foundation Trust, UK
Dr. David Duffy, Massachusetts Vice President, Research and Chief Technology Officer, Quanterix Corporation, USA Dr. Dimiter Dimitrov, Senior Investigator, National Cancer Institute, NIH, USA Dr. Wenzhi Tian, Chairman and CEO, ImmuneOnco Biopharma Co., Ltd, China
Dr.Senyon Choe,
Director, Mogam Biotechnology Institute, Korea
Dr. Weihong Wen, Associate Professor and Vice Director, Fourth Military Medical University, China Dr. Qing Li,
Professor, Sun Yat-Sen University, China
Dr. Yvonne Rosenberg,
President and CEO, PlantVax Inc., USA
Mr. Markus Sack, Research Scientist, RWTH Aachen University, Germany Dr. Jun Tan, Professor,University of South Florida, USA
Dr. Arnaud Avril,
Project Manager, Head of Antibody R&D, Institut de Recherche Biomédicale des Armées (IRBA), France
Dr. Huifang Chen, Professor , University of Montreal , Canada Dr. Syamasis Bandyopadhyay, Physician, Apollo Gleneagles Hospitals, India
Dr. Tianlei Ying, Professor, Fudan University, China Dr. Katharina Uhlig, Application Specialist, ALS Automated Lab Solutions GmbH, Germany Dr. Olivier Léger, Connsultant , AtaGenix Laboratories, Wuhan Institute of Biotechnology, China
Dr. Sundeep Kumar Upadhyaya,
Senior Consultant, Apollo Hospitals, India
Dr. Roberto Crea, President and CEO, Protelica, Inc., USA Dr. Tibor Anderlei, Director of Sales and Business Development, Adolf Kühner AG, Switzerland
Dr. Zhenlin Xu,
Associate Professor, South China Agricultural University, China
Dr. Bo Yu,
Founder and CSO, Larix Bioscience LLC, USA
Mr. Ruediger Mechsner, Principal Consultant, Samsung Engineering, Korea
Dr. Cunzheng Zhang,
A Research Professor, Institute of Food safety of Jiangsu Academy of Agricultural Sciences, China
Dr. Musaddeq Hussain, Principal Scientist, Merck Research Laboratories, USA Dr. Rolf G. Werner, Professor, University of Tuebingen, Germany
Dr. Boaz Tirosh, Associate Professor, The Hebrew University of Jerusalem, Israel Ms. Xingmei Tan,
Senior Engineer, Abcam Hangzhou, China
Dr. Dennis Lin,
Associate Principal Scientist,Mycenax Biotech Inc., Taiwan
Mr. Loany Calvo Gonzalez ,
Senior Director , Bio-Thera Solutions, China
Dr. Fufeng Liu,
Professor, Tianjin University of Science & Technology, China
Ms. Ningling Wang, Managing Partner, Shanghai Representative Office of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, China
Exhibition and Sponsorship

ICA-2018 provides an ideal platform to showcase your new technologies and products in Washington, USA. It is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations.

ICA-2018 is one of the most effective international marketing platforms in the field of Antibody, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.

Company List
News Updates
Hosting Organization
Official Travel Agency
BIT's Upcoming Events
©2016-2017 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609-801-801, : 0086-411-84799609-801